COMMUNIQUÉS West-GlobeNewswire

PhaseBio Appoints Caroline M. Loewy to Board of Directors

19/07/2018 - 14:00

MALVERN, Pa., July 19, 2018 (GLOBE NEWSWIRE) -- PhaseBio Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company focused on the development of therapies for orphan diseases with an initial focus on [...]

Mersana Therapeutics Announces Partial Clinical Hold for XMT-1522 Clinical Trial

19/07/2018 - 14:00

CAMBRIDGE, Mass., July 19, 2018 (GLOBE NEWSWIRE) -- Mersana Therapeutics, Inc.(NASDAQ:MRSN), a clinical-stage biopharmaceutical company focused on discovering and developing a pipeline of antibody drug conjugates (ADCs [...]

HempAmericana CEO Issues New Letter to Shareholders

19/07/2018 - 14:00

NEW YORK, July 19, 2018 (GLOBE NEWSWIRE) -- via OTC PR WIRE--HempAmericana, Inc. (OTC:HMPQ) (“HempAmericana” or the “Company”) CEO issues the following letter to Shareholders: Dear Valued Shareholder, As we navigate the [...]

Abattis Enters Into Definitive Agreement to Sell Northern Vine Interest

19/07/2018 - 14:00

VANCOUVER, British Columbia, July 19, 2018 (GLOBE NEWSWIRE) -- Abattis Bioceuticals Corp. (the " Company " or " Abattis ") (CSE:ATT) (OTC:ATTBF) is pleased to announce that it has entered into a definitive agreement ( [...]

Tetra Natural Health Announces Upcoming Launch of Hemp Energy Drink

19/07/2018 - 14:00

ORLEANS, Ontario, July 19, 2018 (GLOBE NEWSWIRE) -- Tetra Natural Health Inc., a division of Tetra Bio-Pharma Inc. (“Tetra” or the “Company”) (TSX VENTURE:TBP) (OTCQB:TBPMF), announced that it will be commercializing [...]

Epizyme Announces Date of Second Quarter 2018 Financial Results and Business Update Conference Call

19/07/2018 - 13:30

CAMBRIDGE, Mass., July 19, 2018 (GLOBE NEWSWIRE) -- Epizyme, Inc. (NASDAQ:EPZM), a clinical-stage company developing novel epigenetic therapies, today announced that it plans to report its second quarter 2018 financial [...]

Misonix Names Leading Medical Device Executive Gwen Watanabe to Board of Directors

19/07/2018 - 13:30

Current Teleflex Incorporated Executive and Accomplished Industry Entrepreneur Brings Strategic Leadership and Deep Expertise with Growing Medical Device Companies to the Misonix Board FARMINGDALE, N.Y., July 19, 2018 ( [...]

ReWalk Completes Amendment with Wyss Institute at Harvard University to Extend Agreement to June 2022

19/07/2018 - 13:00

Allows Company to Complete Additional Research Programs, Pace Efforts More Efficiently and Benefit Cash Flow MARLBOROUGH, Mass. and YOKNEAM ILIT, Israel, July 19, 2018 (GLOBE NEWSWIRE) -- ReWalk Robotics, Ltd. (Nasdaq: [...]

Allakos Announces Pricing of Initial Public Offering

19/07/2018 - 13:00

SAN CARLOS, Calif., July 19, 2018 (GLOBE NEWSWIRE) -- Allakos Inc., (Nasdaq:ALLK), a clinical stage biotechnology company focused on the development of antibodies for the treatment of various eosinophil and mast cell [...]

NeuroMetrix Reports Q2 2018 Financial Results

19/07/2018 - 13:00

Initial $3.8M Milestone Achieved under GSK Strategic Collaboration WALTHAM, Mass., July 19, 2018 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq:NURO), today reported financial and business highlights for the quarter [...]

Emerald Health Therapeutics Completes Full Acquisition of Licensed Dealer Northern Vine to Advance Product Innovation

19/07/2018 - 12:56

Acquisition expands Emerald’s business to analytical testing services and import/export opportunities facilitated by dealer license VICTORIA, British Columbia, July 19, 2018 (GLOBE NEWSWIRE) -- Emerald Health [...]

DBV Technologies : Monthly information regarding the total number of voting rights and total number of shares of the Company

19/07/2018 - 12:31

Monthly information regarding the total number of voting rights and total number of shares of the Company (Article 223-16 of the General Regulations of the Autorité des Marchés Financiers ) Market : NYSE Euronext Paris [...]

DBV Technologies: Information mensuelle relative au nombre total des droits de vote et d'actions composant le capital social

19/07/2018 - 12:31

Information mensuelle relative au nombre total des droits de vote et d'actions composant le capital social (Article 223-16 du Règlement Général de l'Autorité des Marchés Financiers) Place de cotation : NYSE Euronext [...]

Capital Senior Living Corporation Announces Release Date for Second Quarter 2018 Financial Results

19/07/2018 - 12:00

DALLAS, July 19, 2018 (GLOBE NEWSWIRE) -- Capital Senior Living Corporation (NYSE:CSU) will host a conference call with senior management to discuss the Company’s second quarter 2018 financial results. The call will be [...]

OraSure Technologies Earnings Conference Call Invitation

19/07/2018 - 12:00

2018 Second Quarter Earnings Conference Call Wednesday, August 8, 2018, 5:00 p.m. ET BETHLEHEM, Pa., July 19, 2018 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ:OSUR) has scheduled its regular earnings [...]

Vical Announces Review of Potential Strategic Transactions

19/07/2018 - 12:00

SAN DIEGO, July 19, 2018 (GLOBE NEWSWIRE) -- Vical Incorporated (Nasdaq:VICL) today announced that its Board of Directors plans to explore a range of strategic options to enhance shareholder value. The company has [...]

Medigus Announces Pricing of $10 Million Underwritten Public Offering

19/07/2018 - 12:00

OMER, Israel, July 19, 2018 (GLOBE NEWSWIRE) -- Medigus Ltd. (“Medigus” or the “Company”) (NASDAQ:MDGS) (TASE:MDGS), a medical device company developing minimally invasive endosurgical tools and a leader in direct [...]

PotNetwork Holdings, Inc. Retains Major Law Firms For Guidance on Intellectual Property and FDA Product Registrations

19/07/2018 - 12:00

FT LAUDERDALE, Fla., July 19, 2018 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- PotNetwork Holdings, Inc. (OTC Pink:POTN) announces today that the company has engaged national law firms in Fort Lauderdale, Florida and [...]

HealthLynked Corp. Announces Closing of $2,000,000 Private Placement

19/07/2018 - 11:00

NAPLES, Fla., July 19, 2018 (GLOBE NEWSWIRE) -- HealthLynked Corp. (OTCQB:HLYK), announced today that it has closed a $2,000,000 private placement of common stock and warrants with an institutional investor. [...]